Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
17.57B | 18.41B | 18.21B | 16.32B | 15.13B | Gross Profit |
17.57B | 19.21B | 18.21B | 16.32B | 15.13B | EBIT |
17.57B | 11.05B | 10.52B | 6.80B | 1.16B | EBITDA |
0.00 | 0.00 | 7.17B | 9.72B | 3.96B | Net Income Common Stockholders |
4.42B | 5.46B | 5.46B | 5.78B | 1.32B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
62.68B | 139.41B | 91.63B | 76.57B | 73.56B | Total Assets |
906.70B | 881.45B | 877.83B | 886.52B | 871.27B | Total Debt |
80.92B | 93.67B | 84.55B | 84.66B | 101.66B | Net Debt |
18.24B | 14.65B | -7.08B | 8.09B | 28.10B | Total Liabilities |
860.81B | 834.09B | 830.31B | 84.66B | 101.66B | Stockholders Equity |
45.72B | 47.16B | 47.28B | 52.92B | 49.18B |
Cash Flow | Free Cash Flow | |||
-8.76B | 1.35B | 18.16B | 3.39B | 24.27B | Operating Cash Flow |
-4.39B | 6.81B | 22.01B | 6.62B | 27.17B | Investing Cash Flow |
-7.69B | -9.82B | 510.00M | -2.54B | -4.00B | Financing Cash Flow |
-5.93B | -8.46B | -6.61B | -3.23B | -5.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $55.99B | 11.70 | 9.95% | 3.87% | 36.29% | -19.79% | |
76 Outperform | $56.84B | 8.80 | 20.84% | 6.13% | -7.01% | 15.18% | |
73 Outperform | $61.47B | 11.30 | 11.15% | 4.17% | 7.24% | 7.51% | |
70 Neutral | $59.52B | 10.09 | 11.51% | 5.21% | 5.59% | 15.52% | |
66 Neutral | $60.11B | 10.47 | 8.56% | 2.40% | 13.63% | 27.77% | |
63 Neutral | $12.75B | 9.36 | 8.64% | 84.32% | 13.82% | -3.89% | |
55 Neutral | $46.20B | 10.63 | 0.10% | 5.79% | -26.77% | ― |